Company intelligence
Bio-Techne
About Bio-Techne
Bio-Techne is a global life sciences company that empowers scientific discovery and advances human health. Through its industry-leading branded product portfolios, including R&D Systems™ by Bio-Techne, Bio-Techne Spatial™, and Bio-Techne Diagnostics™, the company delivers high-quality solutions and expert support that enable scientists and clinicians to make breakthrough discoveries, develop and manufacture novel therapeutics and deliver precision diagnostics across cancer research, neuroscience, diabetes, rare diseases, and beyond. Bio-Techne®, Bio-Techne Diagnostics™, Bio-Techne Spatial ™, R&D Systems™ are trademarks or registered trademarks of Bio-Techne Corporation and affiliated entities. All other trademarks, service marks, and trade names are the property of their respective owners.
Verified activity
Signals from Bio-Techne
27 published signals
Presence & Recognition
Bio-Techne is exhibiting at World ADC 2026 in San Diego from October 13-14th, featuring Simple Western on Jess & Maurice Technologies.
Reported by Andy Clarke
Presence & Recognition
Bio-Techne is hosting a webinar presenting a data-driven strategy for developing multianalyte potency assays that pairs broad biomarker discovery with sensitive, automated protein quantification for CD19 CAR-T and CAR-NK cells.
Reported by Andy Clarke
Research & Knowledge
Bio-Techne published a study in Dahl salt-sensitive rats showing that albuminuria appeared within one day of a high-salt diet before measurable differences in blood pressure, accompanied by increased urinary inflammatory markers including CCL2 and renal macrophage accumulation.
Reported by Andy Clarke
Presence & Recognition
Bio-Techne is hosting a networking event in Boston on Wednesday, October 14th, 2026, featuring Maurice and MauriceFlex platforms.
Reported by Jocelyn Dunn
Presence & Recognition
Bio-Techne is hosting an event at the NC Biotech Center in Durham, NC, from 9:00am to 3:00pm featuring protein analysis, Simple Western Platforms, and networking.
Reported by Jessie Ou
Presence & Recognition
Bio-Techne is hosting a webinar featuring Arnaud Delobel and Nicki Zhang to discuss icIEF fractionation workflows enabling downstream characterization of biotherapeutic charge variants using LC-MS.
Reported by Anna Amato (Sinsigalli)
Presence & Recognition
Bio-Techne is hosting an upcoming webinar featuring insights from a core facility team using microfluidic cell sorting across multiple workflows, including neuronal cell isolation to genome engineering and nuclei-based analysis.
Reported by Andy Clarke
Products & Services
Bio-Techne is now offering the new USP mAb 004 (IgG4) standard as a reference material for analytical method development, qualification, and routine performance monitoring.
Reported by Anna Amato (Sinsigalli)
Presence & Recognition
Bio-Techne is hosting a webinar exploring spatial multiomic approaches for RNA therapeutics, ASOs, and siRNAs.
Reported by Joan Raouf
Products & Services
Bio-Techne released the new USP mAb 004 (IgG4) standard as an additional well-characterized mAb reference material for analytical method development, qualification, and routine performance monitoring.
Reported by Andy Clarke
Presence & Recognition
Bio-Techne is hosting a networking event in Boston on Wednesday, October 14th, 2026, featuring Maurice and MauriceFlex platforms.
Reported by Anna Amato (Sinsigalli)
Research & Knowledge
Bio-Techne published an article exploring how combining microfluidic single-cell dispensing with automated capillary-based Western immunoassays can support efficient characterization of engineered cells and streamline development workflows.
Reported by Jessie Ou
Operations & Supply
Bio-Techne set and validated its science-based remission reduction targets with a diverse multidisciplinary team including Erin Woodward, Michelle Eul, Anna Weispfenning, Alyssa Mason, Laurie Gilman, Carolin Spiegel, Jennifer Moore, Lindsey Rodger, Gary Latham, David Clair, CFA, MBA, Mary Anne Mashl Williams, Ken Fairleigh, Rachel Esbjornsson, Sarah Gatherum, Andrea LaGrone, and Cheryl Bethune.
Reported by Shane Bohnen
Legal & Regulatory
Bio-Techne has validated its near-term greenhouse gas emissions reduction targets by the Science Based Targets initiative (SBTi) for Scope 1 and 2 emissions by 2031 and Scope 3 emissions by 2030.
Reported by Bio-Techne
Presence & Recognition
Bio-Techne is hosting an event at the NC Biotech Center - Dogwood Room on September 1, 2026, from 9:00am to 3:00pm featuring protein analysis, Simple Western Platforms, and networking.
Reported by Jeffery Clubs
Legal & Regulatory
Bio-Techne achieved Science Based Targets initiative validation, achieving a 49% reduction in operational emissions and over 50% renewable electricity usage.
Reported by Genevieve Soares
Presence & Recognition
Bio-Techne is hosting a networking and learning event in Boston on Wednesday, October 28th, 2026 at CIC Cambridge.
Reported by Jeffery Clubs
Products & Services
Bio-Techne created an interactive timeline exploring key milestones in protein analysis, from SDS-PAGE and Western blotting to automated protein analysis.
Reported by Andy Clarke
Products & Services
Bio-Techne created an interactive timeline exploring protein analysis milestones, from SDS-PAGE and Western blotting to automated protein analysis.
Reported by Priya Rangaraj
Presence & Recognition
Bio-Techne is hosting an event on Tuesday, September 22nd, 2026, at the UCLA Stem Cell and Genome Engineering Center in Los Angeles, California, featuring a virtual event and a conference room CHS13-105.
Reported by Aubrey Wharton III
Products & Services
Bio-Techne created an interactive timeline exploring key milestones in protein analysis, from SDS-PAGE and Western blotting to automated protein analysis.
Reported by Jessie Ou
Products & Services
Bio-Techne created an interactive timeline exploring key milestones in protein analysis, from SDS-PAGE and Western blotting to automated protein analysis.
Reported by Christoph Borek
Products & Services
Bio-Techne is now offering the new USP mAb 004 (IgG4) standard as a reference material for analytical method development, qualification, and routine performance monitoring.
Reported by Jeffery Clubs
Presence & Recognition
Bio-Techne is exhibiting at World ADC 2026 in San Diego from October 13-14th, featuring Simple Western on Jess and Maurice Technologies.
Reported by Anna Amato (Sinsigalli)